BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23840194)

  • 21. Using anti-biofilm peptides to treat antibiotic-resistant bacterial infections.
    de la Fuente-Núñez C; Hancock RE
    Postdoc J; 2015 Feb; 3(2):1-8. PubMed ID: 27563687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
    O'Meara S; Cullum N; Majid M; Sheldon T
    Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Designed Antimicrobial Peptides Against Trauma-Related Cutaneous Invasive Fungal Wound Infections.
    Woodburn KW; Jaynes JM; Clemens LE
    J Fungi (Basel); 2020 Sep; 6(3):. PubMed ID: 32971819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin treatment enhances pseudomonas aeruginosa biofilm formation by increasing intracellular cyclic di-GMP levels, leading to chronic wound infection and delayed wound healing.
    Wei Q; Zhang Z; Luo J; Kong J; Ding Y; Chen Y; Wang K
    Am J Transl Res; 2019; 11(6):3261-3279. PubMed ID: 31312343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNase-mediated eDNA removal enhances D-LL-31 activity against biofilms of bacteria isolated from chronic rhinosinusitis patients.
    Wongkaewkhiaw S; Kanthawong S; Bolscher JGM; Nazmi K; Taweechaisupapong S; Krom BP
    Biofouling; 2020 Oct; 36(9):1117-1128. PubMed ID: 33297738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DEVELOPMENT OF A NEXT-GENERATION ANTIMICROBIAL WOUND DRESSING.
    Metcalf D; Parsons D; Bowler IP
    Acta Med Croatica; 2016 Mar; 70(1):49-56. PubMed ID: 27220190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A real-life clinical evaluation of a next-generation antimicrobial dressing on acute and chronic wounds.
    Walker M; Metcalf D; Parsons D; Bowler P
    J Wound Care; 2015 Jan; 24(1):11-22. PubMed ID: 25543819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial synergy of monolaurin lipid nanocapsules with adsorbed antimicrobial peptides against Staphylococcus aureus biofilms in vitro is absent in vivo.
    Rozenbaum RT; Su L; Umerska A; Eveillard M; Håkansson J; Mahlapuu M; Huang F; Liu J; Zhang Z; Shi L; van der Mei HC; Busscher HJ; Sharma PK
    J Control Release; 2019 Jan; 293():73-83. PubMed ID: 30465823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanocoatings for Chronic Wound Repair-Modulation of Microbial Colonization and Biofilm Formation.
    Mihai MM; Preda M; Lungu I; Gestal MC; Popa MI; Holban AM
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29649179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights into Peptide Mediated Antibiofilm Treatment in Chronic Wound: A Bench to Bedside Approach.
    Radhakrishnan MP; Suryaletha K; Shankar A; Savithri AV; George S; Thomas S
    Curr Protein Pept Sci; 2021; 22(1):50-59. PubMed ID: 33143623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial photodynamic therapy fighting polymicrobial infections - a journey from in vitro to in vivo.
    Karner L; Drechsler S; Metzger M; Hacobian A; Schädl B; Slezak P; Grillari J; Dungel P
    Photochem Photobiol Sci; 2020 Oct; 19(10):1332-1343. PubMed ID: 32996547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [IMPACT OF BIOFILM ON HEALING AND A METHOD FOR IDENTIFYING IT IN THE WOUND].
    Skrlin J
    Acta Med Croatica; 2016 Mar; 70(1):29-32. PubMed ID: 27220187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial resistance among aerobic biofilm producing bacteria isolated from chronic wounds in the tertiary care hospitals of Peshawar, Pakistan.
    Rahim K; Qasim M; Rahman H; Khan TA; Ahmad I; Khan N; Ullah A; Basit A; Saleha S
    J Wound Care; 2016 Aug; 25(8):480-6. PubMed ID: 27523661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Peptide-Based Antimicrobial Wound Treatment is Effective Against Biofilms of Multi-Drug Resistant Wound Pathogens.
    Bayramov D; Li Z; Patel E; Izadjoo M; Kim H; Neff J
    Mil Med; 2018 Mar; 183(suppl_1):481-486. PubMed ID: 29635548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents.
    Tzitzilis A; Boura-Theodorou A; Michail V; Papadopoulos S; Krikorian D; Lekka ME; Koukkou AI; Sakarellos-Daitsiotis M; Panou-Pomonis E
    J Pept Sci; 2020 Jul; 26(7):e3254. PubMed ID: 32567085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic resistance and biofilm tolerance: a combined threat in the treatment of chronic infections.
    Bowler PG
    J Wound Care; 2018 May; 27(5):273-277. PubMed ID: 29738295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D-LL-31 in combination with ceftazidime synergistically enhances bactericidal activity and biofilm destruction in
    Wongkaewkhiaw S; Taweechaisupapong S; Anutrakunchai C; Nazmi K; Bolscher JGM; Wongratanacheewin S; Kanthawong S
    Biofouling; 2019 May; 35(5):573-584. PubMed ID: 31282211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Antibacterial Effects of Antimicrobial Peptides OP-145 against Clinically Isolated Multi-Resistant Strains.
    Ming L; Huang JA
    Jpn J Infect Dis; 2017 Nov; 70(6):601-603. PubMed ID: 28890511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the Antimicrobial Peptide SE-33-A2P, a Modified Analog of Cathelicidin, and an Analysis of Its Properties.
    Gasanov V; Vorotelyak E; Vasiliev A
    Antibiotics (Basel); 2024 Feb; 13(2):. PubMed ID: 38391576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biodistribution of the cationic host defense peptide LL-37 using SPECT/CT.
    Esposito TVF; Rodríguez-Rodríguez C; Blackadar C; Kłodzińska S; Mørck Nielsen H; Saatchi K; Häfeli UO
    Eur J Pharm Biopharm; 2024 Jul; ():114398. PubMed ID: 38972467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.